QALYs: The Basics

被引：515

作者：

Weinstein, Milton C. ^{[1
]}

Torrance, George ^{[2
]}

McGuire, Alistair ^{[3
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA

[2] McMaster Univ, Hamilton, ON, Canada

[3] London Sch Econ, London WC2A 2AE, England

来源：

VALUE IN HEALTH | 2009年 / 12卷

基金：

美国医疗保健研究与质量局;

关键词：

quality-adjusted life-year; cost-effectiveness analysis; preference; utility; standard gamble; time trade-off; taxonomy; theory; HEALTHY-YEARS EQUIVALENTS; ADJUSTED LIFE YEARS; UTILITY;

D O I：

10.1111/j.1524-4733.2009.00515.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：S5 / S9

页数：5

共 11 条

[1] Making descriptive use of prospect theory to improve the prescriptive use of expected utility [J].

Bleichrodt, H ;

Pinto, JL ;

Wakker, PP .

MANAGEMENT SCIENCE, 2001, 47 (11) :1498-1514

[2] Interpretations of utility and their implications for the valuation of health [J].

Dolan, Paul ;

Kahneman, Daniel .

ECONOMIC JOURNAL, 2008, 118 (525) :215-234

[3] HEALTH-STATUS INDEX AND ITS APPLICATION TO HEALTH-SERVICES OUTCOMES [J].

FANSHEL, S ;

BUSH, JW .

OPERATIONS RESEARCH, 1970, 18 (06) :1021-&

[4] ARE HEALTHY-YEARS EQUIVALENTS AN IMPROVEMENT OVER QUALITY-ADJUSTED LIFE YEARS [J].

JOHANNESSON, M ;

PLISKIN, JS ;

WEINSTEIN, MC .

MEDICAL DECISION MAKING, 1993, 13 (04) :281-286

[5] QUALITY-ADJUSTED LIFE YEARS, UTILITY-THEORY, AND HEALTHY-YEARS EQUIVALENTS [J].

MEHREZ, A ;

GAFNI, A .

MEDICAL DECISION MAKING, 1989, 9 (02) :142-149

[6] QALYs: Some Challenges [J].

Nord, Erik ;

Daniels, Norman ;

Kamlet, Mark .

VALUE IN HEALTH, 2009, 12 :S10-S15

[7] Recommendations for reporting cost-effectiveness analyses [J].

Siegel, JE ;

Weinstein, MC ;

Russell, LB ;

Gold, MR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16) :1339-1341

[8]

Sutherland H J, 1982, Med Decis Making, V2, P299, DOI 10.1177/0272989X8200200306

[9]

Torrance G W, 1972, Health Serv Res, V7, P118

[10] Utility measurement in healthcare - The things I never got to [J].

Torrance, George W. .

PHARMACOECONOMICS, 2006, 24 (11) :1069-1078

← 1 2 →